Clinical utility of SERUM extracelullar domain of HER2 receptor (ECD) in HER2-positive breast cancer.

Ariadna Gasol Cudós,Serafín Morales Murillo,Joel Veas Rodriguez,Carles Canosa Morales,Jordi Melé Olivé,Antonia Salud

Clinical utility of SERUM extracelullar domain of HER2 receptor (ECD) in HER2-positive breast cancer.

2019

Ariadna Gasol Cudós
Serafín Morales Murillo
Joel Veas Rodriguez
Carles Canosa Morales
Jordi Melé Olivé
Antonia Salud

e12086Background: Although ECD expression was validated as tumor marker years ago, it is not used in daily clinical practice even if a prognostic value was demonstrated in some trials. Methods: In ...

Keywords:

Clinical Practice
Pathology
HER2 Positive Breast Cancer
Oncology
Tumor marker
Internal medicine
Receptor
Medicine
her2 receptor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations